- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
IUD placement within 48 hours after second-trimester abortion non inferior to placement after 2 to 4 weeks: Study

Researchers have found that intrauterine device (IUD) placement within 48 hours of a second-trimester medical abortion is associated with increased expulsion rates and lower long-term use compared with placement at 2 to 4 weeks. A recent study was conducted by Sara H. and colleagues published in the American Journal of Obstetrics and Gynecology.
The aim of the research was to establish whether IUD placement within 48 hours would yield higher proportions of women using IUDs at six months post abortion without compromising safety and comfort compared with placement at 2 to 4 weeks postabortion. Eligible study participants were women aged 18 years or older who presented for a second-trimester medical abortion and consented to an IUD. Participants were randomly allocated to receive an IUD within 48 hours of abortion completion or at a later interval, 2 to 4 weeks postabortion. To assess the outcomes, the study made use of modified intention-to-treat and per-protocol analyses, using statistical tests to compare differences.
Six months after placement, more women continued using the IUD in the delayed-placement group (48 of 67) compared with the early-placement group (34 of 67; P.02). The difference was 20.9% (95% CI, 4.4%–35.9%).
The principal negative consequence of early placement was an expulsion rate that was markedly higher than that in the control group.
Compared with the control group (2.9%, or 2 of 70), 30.1% of patients (22 of 73) in the intervention group had IUD expulsion within 48 hours, leading to premature study termination when rates exceeded the prespecified threshold of 20% (P<.001).
While there was a difficulty experienced during expulsion, adverse events and complications were few, with good acceptability in participants across both groups.
It indicates that though the danger of expulsion is more where it is placed early on, it can still remain a choice for women that intend to start on their contraceptives right away but after proper counseling for risk.
There was no six-month usage rate benefit for sixteenth-week abortion followed by the placement of an intrauterine device within 48 hours compared with 2 to 4 weeks after the placement. A postabortion contraceptive plan, therefore, must be individualized so that timing is both in accordance with medical recommendations and with the patient's needs.
Reference:
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751